Metformin is associated with reduced risk of mortality and morbidity in burn patients compared to insulin.
Saved in:
| Title: | Metformin is associated with reduced risk of mortality and morbidity in burn patients compared to insulin. |
|---|---|
| Authors: | Hallman, Taylor G.1 (AUTHOR), Golovko, Georgiy2 (AUTHOR), Song, Juquan1 (AUTHOR), Palackic, Alen1,3 (AUTHOR), Wolf, Steven E.1 (AUTHOR), El Ayadi, Amina1 (AUTHOR) amelayad@utmb.edu |
| Source: | Burns (03054179). Sep2024, Vol. 50 Issue 7, p1779-1789. 11p. |
| Database: | Academic Search Ultimate |
| ISSN: | 03054179 |
|---|---|
| DOI: | 10.1016/j.burns.2024.05.015 |
